About Istituto Regina Elena, Divisione di Oncologia Medica
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute, Naples
4
Clinical Trials at Istituto Regina Elena, Divisione di Oncologia Medica
During the past decade, Istituto Regina Elena, Divisione di Oncologia Medica conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer
2003-01-01
2023-12-01
Active, not recruiting
820
TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung Cancer
2006-12-01
2012-06-01
Completed
760
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
2003-01-01
2006-07-01
Completed
400
G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients
2000-11-01
2009-02-01
Completed
85
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Regina Elena, Divisione di Oncologia Medica"
#1 collaborator was "Princess Margaret Hospital, Canada" with 1 trials as a collaborator, "San Giuseppe Moscati Hospital" with 1 trials as a collaborator, "University of Alberta" with 1 trials as a collaborator and "University of Campania "Luigi Vanvitelli"" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Istituto Regina Elena, Divisione di Oncologia Medica
According to Clinical.Site data, the most researched conditions in "Istituto Regina Elena, Divisione di Oncologia Medica" are
"Advanced Non-Small Cell Lung Cancer" (1 trials), "Advanced Non-small Cell Lung Cancer" (1 trials), "Ovarian Cancer" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Istituto Regina Elena, Divisione di Oncologia Medica" in a lesser frequency.
Clinical Trials Intervention Types at Istituto Regina Elena, Divisione di Oncologia Medica
Most popular intervention types in "Istituto Regina Elena, Divisione di Oncologia Medica" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "cisplatin" (3 trials), "gemcitabine" (3 trials), "carboplatin" (2 trials), "erlotinib" (1 trials) and "etoposide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Istituto Regina Elena, Divisione di Oncologia Medica
The vast majority of trials in "Istituto Regina Elena, Divisione di Oncologia Medica" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Istituto Regina Elena, Divisione di Oncologia Medica
Currently, there are NaN active trials in "Istituto Regina Elena, Divisione di Oncologia Medica".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Istituto Regina Elena, Divisione di Oncologia Medica,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Istituto Regina Elena, Divisione di Oncologia Medica, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".